Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 12
-Section 13
-Sentence Column B

+ Details

Name:	invest_DerivativeNotionalAmount
Namespace Prefix:	invest_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_DerivativeLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959

+ Details

Name:	us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Foreign Currency Option Premium

+ References

No definition available.

+ Details

Name:	var_ForeignCurrencyOptionPremium
Namespace Prefix:	var_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionAxis=var_SirtexMedicalLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_AcquisitionRelatedCostsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Derivative Instruments and Hedging Activities - Sirtex (Details) $ in Millions, $ in Millions	1 Months Ended	12 Months Ended
	Feb. 28, 2018 USD ($)	Sep. 28, 2018 USD ($)	Sep. 29, 2017 USD ($)	Sep. 30, 2016 USD ($)	May 25, 2018 USD ($)	Feb. 28, 2018 AUD ($)
Derivative [Line Items]
Foreign currency option premium		$ 5.5	$ 0.0	$ 0.0
Loss on foreign currency contracts that do not qualify for hedge accounting		5.5	$ 0.0	$ 0.0
Sirtex Medical Limited
Derivative [Line Items]
Loss on foreign currency contracts that do not qualify for hedge accounting		29.7
Sirtex Medical Limited \| Foreign Exchange Forward
Derivative [Line Items]
Notional amount	$ 621.0				$ 596.8	$ 793.0
Foreign currency option premium	5.5
Sirtex Medical Limited \| Foreign Exchange Option
Derivative [Line Items]
Notional amount	$ 641.5					$ 792.0
Acquisition-related Expenses \| Sirtex Medical Limited \| Foreign Exchange Forward
Derivative [Line Items]
Loss on foreign currency contracts that do not qualify for hedge accounting		24.2
Acquisition-related Expenses \| Sirtex Medical Limited \| Foreign Exchange Option
Derivative [Line Items]
Loss on foreign currency contracts that do not qualify for hedge accounting		$ 5.5